Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Wijermans

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|August 23, 2002
[Thalidomide in the treatment of refractory multiple myeloma: a Dutch study of 72 patients: an antitumor effect in 45%]K L Wu, M R Schaafsma, H M Lokhorst, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 27, 2005
[Modern treatment methods for multiple myeloma: guidelines from the Dutch Haemato-Oncology Association (HOVON)]H Lokhorst, P C Huijgens, R Raymakers, et al.
Journal of Neuro-Oncology|December 1, 1990
Longterm meningeal involvement as the only clinical manifestation of low grade malignant non-Hodgkin's lymphomaJ J Heimans, P W Wijermans, C H Polman, et al.
Leukemia Research|January 1, 1987
Quantitative enzyme determination; a parameter for leukemic cell differentiationP W Wijermans, G J Ossenkoppele, P C Huijgens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin's lymphoma registryE Maartense, S Le Cessie, H C Kluin-Nelemans, et al.
Leukemia & Lymphoma|February 26, 1998
Development of a "Myeloma Risk Score" using a population-based registry on paraproteinemia and myelomaF Ong, J Hermans, E M Noordijk, et al.
British Journal of Haematology|February 1, 1995
Long-term treatment with interferon-alpha 2b for severe pruritus in patients with polycythaemia veraE W Muller, J T de Wolf, R Egger, et al.
Leukemia Research|January 1, 1992
Monocytic differentiation induction of HL-60 cells by MC 903, a novel vitamin D analogueV I Rebel, G J Ossenkoppele, A A van de Loosdrecht, et al.
Lancet (London, England)|April 8, 1995
Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?M den Heijer, H J Blom, W B Gerrits, et al.
Leukemia|October 29, 2004
Analysis of efficacy and toxicity of thalidomide in 122 patients with multiple myeloma: response of soft-tissue plasmacytomasK L Wu, H H Helgason, B van der Holt, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Nederlands Tijdschrift Voor Geneeskunde|August 23, 2002
[Thalidomide in the treatment of refractory multiple myeloma: a Dutch study of 72 patients: an antitumor effect in 45%]K L Wu, M R Schaafsma, H M Lokhorst, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 27, 2005
[Modern treatment methods for multiple myeloma: guidelines from the Dutch Haemato-Oncology Association (HOVON)]H Lokhorst, P C Huijgens, R Raymakers, et al.
Journal of Neuro-Oncology|December 1, 1990
Longterm meningeal involvement as the only clinical manifestation of low grade malignant non-Hodgkin's lymphomaJ J Heimans, P W Wijermans, C H Polman, et al.
Leukemia Research|January 1, 1987
Quantitative enzyme determination; a parameter for leukemic cell differentiationP W Wijermans, G J Ossenkoppele, P C Huijgens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin's lymphoma registryE Maartense, S Le Cessie, H C Kluin-Nelemans, et al.
Leukemia & Lymphoma|February 26, 1998
Development of a "Myeloma Risk Score" using a population-based registry on paraproteinemia and myelomaF Ong, J Hermans, E M Noordijk, et al.
British Journal of Haematology|February 1, 1995
Long-term treatment with interferon-alpha 2b for severe pruritus in patients with polycythaemia veraE W Muller, J T de Wolf, R Egger, et al.
Leukemia Research|January 1, 1992
Monocytic differentiation induction of HL-60 cells by MC 903, a novel vitamin D analogueV I Rebel, G J Ossenkoppele, A A van de Loosdrecht, et al.
Lancet (London, England)|April 8, 1995
Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?M den Heijer, H J Blom, W B Gerrits, et al.
Leukemia|October 29, 2004
Analysis of efficacy and toxicity of thalidomide in 122 patients with multiple myeloma: response of soft-tissue plasmacytomasK L Wu, H H Helgason, B van der Holt, et al.
Pageof 9